IN RESPONSE to the major changes in the hospital reimbursement system, many hospitals and hospital departments realized the need to modify their modus operandi to maintain their present budget levels or to position themselves to at least minimize budget reduction. Although it is still early in the process and no one knows the real impact of diagnosis-related groups and prospective reimbursement, most believe that health-care dollars for inpatient care will be limited and the competition for these dollars will become more intense. Keeping this concept in mind, strategic planning, under any prospective reimbursement system, becomes more of a prescription for survival for departments such as pharmacy.
In reviewing the pharmacy literature for the last two years, it is evident that pharmacy is keenly aware of its need to change to accommodate its new environment. We, as part of the practicing community, applaud the energy and talents that our profession is exerting to cope with the new environmental changes. However, a closer look at the direction taken by most articles dealing with this issue is disconcerting. We believe that the direction our profession might be adopting could possibly stunt the growth of pharmacy practice, especially that growth related to the clinical role. We also believe that limiting the growth of clinical pharmacy will be detrimental to incorporating pharmacists as integral and important members of the patient care team.
Focusing on the so-called target-specific programs, a concept highlighted in an article by Abramowitz and Nold;' the problems of equitable remuneration and the future of clinical pharmacy practice surface. In one instance, one such target-specific program showed a savings of $157000 by an investment of $I6000 to compensate a clinical pharmacist to monitor specific drugs.' The potential problem with this approach is that although it has dynamic results, only a small number of such programs will be developed. Also, once pharmacists have educated the people involved with the savings, should the program continue? If aminoglycosides become obsolete in two to five years due to newer and less toxic agents, will we need aminoglycoside kinetic programs? A serious question that must be raised is whether pharmacy is headed for what economists label as "planned obsolescence." These comments should not be construed as advocating stagnation or a backward approach, but rather to encourage long-range strategy.
Similar to the present approach is the direction many pharmacists took in the late 70s when the move for reimbursement for clinical pharmacy services started. The Ohio State University pharmacy group demonstrated a savings of $835()()() by developing several new programs, but the amount pharmacy received for its effort was less than $20 OOO/yr. J We question how much of this $800000 savings we can demonstrate, and then settle for $20000 in return.
Target programs, i.e., those with the most significant impact in terms of cost-savings and effectiveness, may be appropriate for those hospital pharmacy departments that are trying to contend with limited pharmacy personnel and a no-growth situation. However, at the professional and collective level, it would be wise to contemplate the following. Target programs are limited in number, and concentrating efforts on these programs might have significant repercussions on pharmacy practice. It is obvious that tackling a few target programs will eventually lead to the enactment of the law of diminishing returns. The next best target program in terms of impact on cost-savings might not provide an incentive for the hospital administrator to retain an additional pharmacy full-time equivalent.
We believe that, although the new prospective system will be with us in one form or another, pharmacy should look beyond the immediate beneficial results of programs such as target-specific ones and debate new survival strategies. Our theme is adopted from Schondelmeyer, who presents an excellent review of ways to effect changes in pharmacy practice."
Drawing his thesis from several sources, Schondelmeyer states that the object of strategic change "is to plan and achieve congruence between the needs, and the ability of a given organization, occupation or profession to meet those needs." He believes that the profession should also concern itself with its relationship with:
(1) its environment and (2) its internal structure and operation. These two requirements are referred to as effectiveness and efficiency, respectively. The degree of responsiveness of a profession, in terms of its output, to societal need is described as effectiveness; whereas, the actual input:output ratio is described as efficiency. The need to balance effectiveness and efficiency must be achieved to ensure the continued existence of the profession."
When thinking of survival strategies and strategic planning, effectiveness should take on an added dimension. Time becomes an important element in this dimension in that, in the long run, the final test of an organization's effectiveness is its ability to sustain itself in the environment. Therefore, survival of the organization is the ultimate, or long run, measure of its effectiveness. Dealing with the issue of organizational effectiveness and taking time into account, a model for criteria of organizational effectiveness could be depicted as follows:" A balance must be struck among the three dimensions of effectiveness to ensure the professional growth of pharmacy and to nurture its clinical role. This role entails a total commitment to the drug-use process from drug prescribing to patient outcome. We strongly believe that, in terms of strategic planning, pharmacy should pursue and advocate more, not less, control over the drug-use process,":" a process that will not be fully operational under any target-specific program. Commitment of pharmacy to the drug-use process means the adoption of the dynamic rather than a static approach to problem-solving." With the static approach, a traditionally accepted modality of practice, pharmacy directors tend to confine their responsibilities to the costs of personnel and supplies within their departments. By contrast, the dynamic approach recognizes that decisions related to the products and services of pharmacy are normally made outside the pharmacy. Hence, pharmacy ought to try to gain some control over the decisionmaking process related to both the products distributed by pharmacy and the drug information circumscribing these products. 9 Striving to gain control over this process by adopting the dynamic approach should be the single most important long-term strategic goal for pharmacy.
Our contention is that maximum benefits will be realized for both the profession and society if pharmacists assume a much greater control over the drug-use process, not relinquishing parts of the clinical role it struggled to establish. The move toward the clinical role started in the late 60s and 70s when there was a perceived need for drug therapy-drug control experts who had to be on hand to make prospective decisions about drug therapy. This need stemmed from the increasing complexity of drugs and drug therapy and, as such, this argument is more valid today than it was in the last two decades. If pharmacists were denied the opportunity to play an active role in this process, one of the basic premises for the establishment of clinical pharmacy would be eliminated. For educational, acceptance, and visibility purposes, the clinical pharmacist must play an -1~----+---P roduction Criteria Efficiency Satisfaction active role as a member of the health-care team and not just a retrospective role. In the long run, our survival as a profession depends on our positive impact on the delivery of health care and, consequently, our acceptance by the other role players, including the patients. This impact will be determined and measured by our degree of involvement and commitment to the total drug-use process. Pathak anticipates the initial reaction of many hospital pharmacy directors to the DRG environment will be to reduce the pharmacy staff, especially the clinical specialists. He also warns that this initial reaction must be avoided since "such a strategy leads to reducing the hospital pharmacy to an ancillary or support service department primarily responsible for drug distribution."!" Therefore, pharmacy should not make concessions, especially since, in light of the new system, all territorial domain may be obsolete. How we mobilize our efforts and how we compromise will affect the practice of pharmacy for years to come. Hence, the issue of strategic planning must be debated within the ranks of our profession. Since strategy is a major factor for the existence or survival of a profession," it is too important to be left to chance. We believe that commitment by pharmacy to the drug-use process will steer the profession in the right direction. Once positive impact statements are provided by pharmacy, favorable changes for the profession will result.
We believe that with the help of the professional pharmacy journals, pharmacy leaders can establish a dialogue and provide the needed leadership to address strategies while there is still time to promote change in a desirable direction for the profession. It is imperative that the profession correct its "lack of commitment" to its future and its" fear of uncertainty." 11 We cannot leave these changes to chance.
